The global cell-based assays market size was USD 14.95 Billion in 2020 and is expected to register a CAGR of 8.5% during the forecast period.
The global cell-based assays market size was USD 14.95 Billion in 2020 and is expected to register a CAGR of 8.5% during the forecast period. Factors such as rising investments in R&D for drug discovery and development, rapid increase in the number of pharmaceutical & biopharmaceutical companies globally, and increasing prevalence of chronic diseases and lifestyle disorders globally are driving market revenue growth.
Cell-based assays are in-vitro assays that aid in various drug development processes. These are used to analyze living cells based on different parameters such as pharmacokinetic and pharmacodynamics studies. These are also used for various applications including cytotoxic testing, proliferation, activation of cell signaling pathways, mechanism of drug substances, and drug potency.
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118247
Demand for cell-based assays has rapidly increased over the past few years, and this is attributable to factors such as technological advancements in cell-based assays along with 3D-based cell assays, high usage of cell-based assays in various drug applications, including drug discovery. Furthermore, high demand for testing drug responses in various organisms and rising need to develop more biologically relevant alternatives for drug discovery are other factors expected to boost market revenue growth going ahead.
Market Dynamics:
Driver: Increasing demand for cell-based assays in drug discovery
Recent advancements in cell-based assays and increasing popularity and usage of cell-based assays in drug development processes is a significant factor boosting growth of the cell-based assays market. These methods are less expensive, consume minimum time, and offer high throughput as compared to traditional methods used for cytotoxic testing and drug safety assessment. Moreover, increasing funding for cell-based assays by various private and public organizations is an essential factor surging market revenue growth. Rising number of pharmaceutical and biopharmaceutical companies around the globe coupled with increase in overall drug discovery activities is boosting demand for cell-based assays, which is expected to boost market growth during the forecast period.
Restraint: High priced instruments and stringent regulations on reagent use
Though the global market for cell-based assays is gradually growing, constraints expected to impede revenue growth of the market in the coming years include advancements in technologies such as high-content screening and high-throughput screening has increased the demand for cell-based assays, but costs of these technologies are high. High maintenance cost and initial investment for instruments is a major restraint expected to affect revenue growth between 2021 and 2030. Moreover, unfavorable regulations for using reagent kits for specific assays is expected to hamper market growth during the forecast period. Unavailability of cell-based research in developing countries is another key factor expected to restrain growth of the cell-based assays market during the forecast period.
Product and Services Outlook:
Based on product and services, the global market is segmented broadly into consumables, cell lines, probes & labels, instruments and software, cell lines, and services. Among these, the consumables segment dominated other product and services segments and is projected to account for substantial revenue contribution during the forecast period. Continuous demand for consumables across biopharmaceuticals and pharmaceutical companies and rising number of R&D initiatives on drug discovery are factors also boosting revenue growth of this segment. On the other hand, the services segment is expected to register fastest revenue CAGR of 20% during the forecast period owing to growing reliance of laboratories on cell-based assays to conduct research and development of novel drugs.
Application Outlook:
On the basis of application, the global market is segmented into drug discovery, basic research, and other applications. Drug discovery segment is further sub-segmented into pharmacodynamics studies, toxicity studies, and pharmacokinetic studies. The drug discovery segment accounted for largest revenue share in 2020 and this trend is expected to continue between 2021 and 2030. Other factors, such as rapidly rising investments in R&D, increasing number of CROs for drug discovery services, and innovative drugs for treating various diseases are supporting demand for cell-based assays.
End-Use Outlook:
The global cell-based assays market is segmented into academic & research institutions, contract research organizations, and pharmaceutical & biopharmaceutical companies. The pharmaceutical and biopharmaceutical companies segment accounted for largest revenue share in 2020 and is expected to maintain its lead position during the forecast period. High revenue share is attributed to factors such as growing number of competitive healthcare companies and their collaborative approaches for developing drugs due to increasing demand for enhanced and novel drugs to treat various diseases combined with rising R&D spending. However, the academic & research institutions segment is expected to account for fastest revenue growth throughout the forecast period owing to extensive usage of cell-based assay in various drug discovery-related studies and increasing emphasis on developing cell-based assays for various applications.
Regional Outlook:
Asia Pacific is projected to register fastest revenue CAGR of 11.6% throughout the forecast period. Factors such as rapid technological developments and rising investments in R&D in drug discovery outsourcing and life sciences are escalating demand for cell-based assays and supporting revenue growth of the market in this region. Moreover, increasing prevalence of chronic diseases and rising awareness of these assays is expected to augment growth of the cell-based assays market during the forecast period.
Related Reports:
- Microbial and Bacterial Cellulose Production Market: https://qyresearchmedical.com/report/microbial-and-bacterial-cellulose-production-market-size-share-and-analysis-by-growth-medium-synthetic-media-by-production-method-static-method-by-bacteria-type-gram-negative-bacteria-by-application-phar-ts-to-2030/118253
- Live Cell Encapsulation Market: https://qyresearchmedical.com/report/live-cell-encapsulation-market-size-share-and-analysis-by-technique-simple-dripping-electrostatic-dripping-liquid-jet-break-up-coaxial-airflow-vibrating-jet-jet-cutting-by-polymer-alginate-chitosan-sili-st-to-2030/118254
North America market dominated other regional markets in terms of revenue in 2020 and is expected to maintain its dominance throughout the forecast period. The US is one of the largest contributors to revenue of the North America market owing to high prevalence of various chronic diseases. Rising adoption of cell-based techniques, easy availability of cell-based assays, and robust support from private and governmental organizations for life science research and drug discovery and developmental activities are some key factors fueling revenue growth of the market in this region.
Competitive Landscape:
The global cell-based assays market is fragmented with presence of a number of regional and global players. These players are highly competitive, and focused on various strategies such as mergers, acquisitions, collaborations, and partnerships with other companies to strengthen their market position. Leading companies in the global cell-based assays market are Danaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson, and Company (US), PerkinElmer, Inc. (US), Promega Corporation (US), Charles River Laboratories (US), Lonza (Switzerland), BioAgilytix Labs (US), Reaction Biology Corporation (US), and AAT Bioquest (US).
- In April 2019, PerkinElmer announced acquisition of Cisbio Bioassays, which is a leading Life Science company engaged in manufacturing high-quality reagents and kits. This acquisition is expected to expand PerkinElmer’s offerings of a wide product range in the market.
This report offers historical data points and forecasts and revenue growth at a global, regional, and country-level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2018 to 2030. For this study, Reports and Data has segmented the global cell-based assays market based on product and services, application, end-use, and region:
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118247
Cell-based Assays Market Report Scope
Segments covered By Based On Product And Service, Based On Application, Based On End Use, Regional Outlook
By Based On Product And Service
- Consumables
- Reagents
- Assay Kits
- Reporter Gene Assays
- Cell Growth Assays
- Second Messenger Assays
- Cell Death Assays
- Other Assay Kits
- Cell Lines
- Immortalized Cell Lines
- Primary Cell Lines
- Stem Cell Lines
- Microplates
- Probes & Labels
- Other Consumables
- Instruments & Software
- Services
By Based On Application
- Drug Discovery
- Toxicity Studies
- Pharmacodynamics Studies
- Pharmacokinetic Studies
- Basic Research
- Other Applications
By Based On End Use
- Pharmaceutical & Biopharmaceutical Companies
- CROs
- Academic & Research Institutes
Regional scope
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy quantitative research Report at discounted price - USD 1500 https://qyresearchmedical.com/report/checkout/118247/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL - http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/
https://twitter.com/qyresearchmedi
d.